Bristol-Myers Squibb Co. (BMY)
The income statement presents information on the financial results of a company’s business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.
Bristol-Myers Squibb Co., Consolidated Income Statement
USD $ in millions
|Revenues||Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise.||Bristol-Myers Squibb Co.’s revenues increased from 2016 to 2017 and from 2017 to 2018.|
|Operating income||The net result for the period of deducting operating expenses from operating revenues.||Bristol-Myers Squibb Co.’s operating income declined from 2016 to 2017 but then increased from 2017 to 2018 exceeding 2016 level.|
|Earnings before income taxes||Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.||Bristol-Myers Squibb Co.’s earnings before income taxes declined from 2016 to 2017 but then increased from 2017 to 2018 exceeding 2016 level.|
|Net earnings attributable to BMS||The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.||Bristol-Myers Squibb Co.’s net earnings attributable to BMS declined from 2016 to 2017 but then increased from 2017 to 2018 exceeding 2016 level.|